Design Therapeutics, Inc. (DSGN)
Design Therapeutics, Inc. (DSGN) has reported earnings 21 times since May 10, 2021. The stock moves an average of ±8.34% the day after reporting, closing higher 52.4% of the time. Its largest post-earnings gain was +23.26% (Apr 28, 2026) and its largest decline was -70.46% (Aug 14, 2023). The next earnings report is predicted for 2026-08-06 (estimated).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
21
Avg Abs. Movement
±8.34%
Positive %
52.4%
Negative %
47.6%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| Apr 28, 2026 | ☽ POST | $12.77 | $13.24 | $12.81 | 219,100 | +23.26% | open_in_new |
| Mar 09, 2026 | ☽ POST | $9.93 | $10.43 | $10.37 | 163,300 | -3.66% | open_in_new |
| Nov 05, 2025 | ☽ POST | $6.23 | $6.90 | $6.55 | 86,000 | +4.89% | open_in_new |
| Aug 07, 2025 | ☽ POST | $4.35 | $4.35 | $3.97 | 61,900 | +7.81% | open_in_new |
| May 07, 2025 | ☽ POST | $3.63 | $3.63 | $3.33 | 82,600 | +5.71% | open_in_new |
| Mar 10, 2025 | ☀ PRE | $4.87 | $4.96 | $4.87 | 111,600 | -1.02% | open_in_new |
| Nov 07, 2024 | ☽ POST | $5.92 | $6.20 | $5.79 | 109,100 | +0.69% | open_in_new |
| Aug 05, 2024 | ☀ PRE | $4.69 | $4.92 | $4.66 | 163,400 | -1.69% | open_in_new |
| May 08, 2024 | ☽ POST | $4.66 | $5.23 | $4.69 | 1,283,100 | +1.71% | open_in_new |
| Mar 19, 2024 | ☽ POST | $2.52 | $2.59 | $2.59 | 218,600 | +11.97% | open_in_new |
| Nov 13, 2023 | ☽ POST | $2.02 | $2.09 | $2.05 | 504,200 | +11.71% | open_in_new |
| Aug 14, 2023 | ☽ POST | $7.66 | $7.66 | $7.33 | 160,600 | -70.46% | open_in_new |
| May 09, 2023 | ☽ POST | $7.53 | $7.70 | $7.55 | 163,000 | -11.66% | open_in_new |
| Mar 14, 2023 | ☽ POST | $7.18 | $7.31 | $7.07 | 642,500 | -0.85% | open_in_new |
| Nov 03, 2022 | ☽ POST | $15.13 | $15.63 | $15.49 | 314,400 | -0.19% | open_in_new |
| Aug 08, 2022 | ☽ POST | $22.36 | $22.67 | $21.42 | 78,300 | +2.66% | open_in_new |
| May 09, 2022 | ☽ POST | $11.05 | $11.47 | $11.07 | 240,400 | -0.36% | open_in_new |
| Mar 10, 2022 | ☽ POST | $17.22 | $17.70 | $17.57 | 57,800 | -1.82% | open_in_new |
| Nov 09, 2021 | ☽ POST | $17.97 | $19.11 | $18.91 | 154,800 | +0.11% | open_in_new |
| Aug 09, 2021 | ☽ POST | $15.48 | $16.18 | $15.83 | 83,200 | +6.19% | open_in_new |
| May 10, 2021 | ☽ POST | $28.10 | $29.16 | $28.31 | 119,300 | -6.82% | open_in_new |
Earnings Count
21
Total earnings in dataset
Avg Abs. Movement
±8.34%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| SCHEDULE 13G | 20260609 | open_in_new SEC.gov |
| 8-K | 20260518 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260515 | open_in_new SEC.gov |
| 10-Q | 20260428 | open_in_new SEC.gov |
| 8-K | 20260428 | open_in_new SEC.gov |
| 10-Q | 20260428 | open_in_new SEC.gov |
| 8-K | 20260428 | open_in_new SEC.gov |
| DEFA14A | 20260423 | open_in_new SEC.gov |
| DEF 14A | 20260423 | open_in_new SEC.gov |
| ARS | 20260423 | open_in_new SEC.gov |
Frequently asked about DSGN earnings
When does Design Therapeutics, Inc. report earnings next? expand_more
Design Therapeutics, Inc. (DSGN)'s next earnings date is estimated for 2026-08-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does DSGN stock move after earnings? expand_more
Over 21 reports, DSGN has moved an average of ±8.34% the session after earnings, closing higher 52.4% of the time.
What was DSGN's biggest post-earnings move? expand_more
DSGN's largest post-earnings gain on record was +23.26% on Apr 28, 2026, and its largest decline was -70.46% on Aug 14, 2023.
Where can I find Design Therapeutics, Inc.'s SEC filings? expand_more
All of Design Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right